Noveome Biotherapeutics

Pittsburgh, PA · Founded 2000 · Privately Held (backing)

Developer of novel biotherapeutic products designed to treat inflamed or damaged tissues. Noveome Biotherapeutics is based in Pittsburgh, PA and was founded in 2000. Its last reported valuation was $200 million in Apr 2019. It has raised $78.7 million across 4 recorded rounds; the latest was a $36.2 million early-stage round in Aug 2023.

Last reported valuation
$200.0M
Oct 2026
Priced at
—
Total raised
$78.7M
Last round
Early Stage VC
Aug 2023

Who backs Noveome Biotherapeutics?

10 investors
InvestorType
UPMC EnterprisesVenture capital
Carnegie Mellon UniversityOther
Commonwealth of PennsylvaniaOther
MAK CapitalHedge fund
University of Pittsburgh EndowmentOther
Lancet Capital—
Miraki Innovation—
Redevelopment Authority Of Allegheny County—
Terence Golden—
U.S. Department of Health and Human Services—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Noveome Biotherapeutics investors

10 investors are on record for Noveome Biotherapeutics, including UPMC Enterprises, Carnegie Mellon University, Commonwealth of Pennsylvania and MAK Capital. The early-stage round in Aug 2023 drew 66 investors.

Free account
More of Noveome Biotherapeutics with a free account
  • ·Watch Noveome Biotherapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Noveome Biotherapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View